Novel prospects of statins as therapeutic agents in cancer

scientific article published on 05 July 2014

Novel prospects of statins as therapeutic agents in cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PHRS.2014.06.013
P698PubMed publication ID25009097
P5875ResearchGate publication ID263860323

P50authorMaurizio BifulcoQ39378638
Elena CiagliaQ89745248
P2093author name stringAlba D'Alessandro
Simona Pisanti
Paola Picardi
P304page(s)84-98
P577publication date2014-07-05
P1433published inPharmacological ResearchQ15724622
P1476titleNovel prospects of statins as therapeutic agents in cancer
P478volume88

Reverse relations

cites work (P2860)
Q41882404A remarkable hematological and molecular response pattern in a patient with polycythemia vera during combination therapy with simvastatin and alendronate
Q47125276Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling
Q47193411Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro
Q37058267Cancer prevention and therapy through the modulation of the tumor microenvironment
Q89766082Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders
Q38726939Development of MEPS-UHPLC-MS/MS multistatin methods for clinical analysis
Q36406837Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials
Q30241078Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
Q55049353Evaluation of the Cytotoxic and Autophagic Effects of Atorvastatin on MCF-7 Breast Cancer Cells
Q38572098Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems.
Q40400445Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.
Q26774859Lipid metabolic reprogramming in cancer cells
Q36919251Meta-analysis of studies using statins as a reducer for primary liver cancer risk.
Q47645395Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.
Q52688122Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.
Q100524855Predicting the effect of statins on cancer risk using genetic variants from a Mendelian randomization study in the UK Biobank
Q38668187Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms
Q47096468Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats.
Q33739126Protective effect of Chuquiraga spinosa extract on N-methyl-nitrosourea (NMU) induced prostate cancer in rats
Q55303771Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair.
Q90297451Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Q92648929Statin use and its potential therapeutic role in esophageal cancer: a systematic review and meta-analysis
Q49835350Statin use and pancreatic cancer risk in two prospective cohort studies.
Q38692861Statin use and risk of multiple myeloma: An analysis from the cancer research network.
Q37407449Statins and risk of breast cancer recurrence
Q64120196Statins associate with improved mortality among patients with certain histological subtypes of lung cancer
Q38257464Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?
Q38792334Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Q97074362The Innovative Potential of Statins in Cancer: New Targets for New Therapies
Q60920750The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
Q52727521The complex interplay among hepatocytes and immune cells at the crossroad between inflammation and cholesterol metabolism in hyperglycemia.
Q41471022The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis
Q35915762Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again
Q59111383Towards the Application of Atorvastatin to Intensify Proapoptotic Potential of Conventional Antileukemic AgentsIn Vitro
Q37690366Variability in statin-induced changes in gene expression profiles of pancreatic cancer.
Q91977386[18F]Atorvastatin: synthesis of a potential molecular imaging tool for the assessment of statin-related mechanisms of action

Search more.